2014
DOI: 10.1161/atvbaha.114.303845
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphisms in Catechol- O -Methyltransferase Modify Treatment Effects of Aspirin on Risk of Cardiovascular Disease

Abstract: Objective Catechol-O-methyltransferase (COMT), a key enzyme in catecholamine metabolism, is implicated in cardiovascular, sympathetic, and endocrine pathways. This study aimed to confirm preliminary association of COMT genetic variation with incident cardiovascular disease (CVD). It further aimed to evaluate whether aspirin, a commonly used CVD prevention agent, modified the potential association of COMT with incident CVD. Approach and Results We examined COMT polymorphism rs4680 (MAF=0.47), encoding a non-s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
53
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 39 publications
(56 citation statements)
references
References 36 publications
3
53
0
Order By: Relevance
“…Low COMT activity in the cerebral cortex was found in rats with hypertension compared with normal controls (68), suggesting that COMT activity may regulate blood flow in the cortex. In line with this idea, a recent population study shows that subjects with the Met/Met genotype have significantly higher incidences of cardiovascular disease than subjects with the Val/Val genotype (69). In the present study, subjects with the Met/Met genotype who have lower COMT activity may have experienced less blood vessel dilation during immersion compared with the subjects with the Val/Val genotype.…”
Section: Discussionsupporting
confidence: 76%
“…Low COMT activity in the cerebral cortex was found in rats with hypertension compared with normal controls (68), suggesting that COMT activity may regulate blood flow in the cortex. In line with this idea, a recent population study shows that subjects with the Met/Met genotype have significantly higher incidences of cardiovascular disease than subjects with the Val/Val genotype (69). In the present study, subjects with the Met/Met genotype who have lower COMT activity may have experienced less blood vessel dilation during immersion compared with the subjects with the Val/Val genotype.…”
Section: Discussionsupporting
confidence: 76%
“…The rs4680GG genotype has been associated with a high risk of hypertension (33) and CVD (34), whereas the rs4860AA genotype has been shown to be protective against myocardial infarction in hypertensive patients (35). In contrast, the low COMT activity of the rs4860AA genotype has been shown to be an independent risk factor for acute coronary events in Finnish men (36).…”
Section: Figurementioning
confidence: 99%
“…In this cohort, women were randomly allocated to aspirin or vitamin E, and compared with placebo at 10 years of follow-up. Hall and colleagues have utilized this cohort to examine the effects of the polymorphism (rs4680) of COMT on CVD incidence (17). We considered a subset of the WGHS women allocated to placebo, and used an age-adjusted model (n = 5,814) and a fully adjusted model (n = 5,143) to examine whether the placebome module contains significantly more genes with SNPs that modify the outcome (total CVD and major CVD incidence) in the placebo arm.…”
Section: Resultsmentioning
confidence: 99%
“…Conversely, in other proximal placebome conditions, such as depression (31) and schizophrenia (32), which are known to have high placebo-related responses, activation of the placebome can be presumed to be efficacious in large subsets of patients. Placebome seed genes like COMT have been associated with myriad diseases, including cancer (33), preeclampsia (34), Parkinson disease (35), CVD (17), and psychiatric disorders (36). The proximity of the placebome to diseases that affect women likely derives from the functional interaction of COMT P values were adjusted using the Bonferroni procedure.…”
Section: Resultsmentioning
confidence: 99%